Preliminary Data From Human Clinical Trial Shows Vectomega(R), A Revolutionary Omega-3 Phospholipid Complex (DHA/EPA), Has Positive Results

... EuroPharma's president, TerryLemerond, recently obtained the North America distribution rights to arevolutionary Omega-3 phospholipid complex with DHA/EPA, calledVectomega(R). Molecularly different from other omega-3's on the market,this new complex is 50 times more absorbable across cellular membranes thanother DHA/EPA products and is available as a water/oil soluble powder. [click link for full article] ...